Latest Insider Transactions at Select Medical Holdings Corp (SEM)
This section provides a real-time view of insider transactions for Select Medical Holdings Corp (SEM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SELECT MEDICAL HOLDINGS CORP to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SELECT MEDICAL HOLDINGS CORP's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2024
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
543
+0.19%
|
$17,919
$33.14 P/Share
|
|
Oct 29
2024
|
Parvinderjit S. Khanuja |
BUY
Grant, award, or other acquisition
|
Direct |
543
+1.22%
|
$17,919
$33.14 P/Share
|
|
Oct 27
2024
|
Michael F Malatesta CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
8,828
-4.39%
|
$273,668
$31.74 P/Share
|
|
Oct 27
2024
|
Brian R. Rusignuolo Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,010
-3.26%
|
$341,310
$31.74 P/Share
|
|
Oct 27
2024
|
Thomas P Mullin CO-PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
11,023
-3.05%
|
$341,713
$31.74 P/Share
|
|
Sep 30
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
BUY
Bona fide gift
|
Indirect |
220,000
+5.5%
|
-
|
|
Sep 30
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
SELL
Bona fide gift
|
Direct |
220,000
-46.81%
|
-
|
|
Aug 03
2024
|
Michael E Tarvin EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
35,352
-7.06%
|
$1,201,968
$34.18 P/Share
|
|
Aug 03
2024
|
Thomas P Mullin CO-PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
32,750
-8.31%
|
$1,113,500
$34.18 P/Share
|
|
Aug 03
2024
|
John A. Saich EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
26,094
-3.62%
|
$887,196
$34.18 P/Share
|
|
Aug 03
2024
|
Brian R. Rusignuolo Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,025
-5.86%
|
$714,850
$34.18 P/Share
|
|
Aug 03
2024
|
Martin F Jackson EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
53,028
-3.9%
|
$1,802,952
$34.18 P/Share
|
|
Aug 03
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Payment of exercise price or tax liability
|
Direct |
87,880
-1.27%
|
$2,987,920
$34.18 P/Share
|
|
Aug 03
2024
|
David S Chernow PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
88,380
-8.04%
|
$3,004,920
$34.18 P/Share
|
|
Aug 01
2024
|
David S Chernow PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
73,650
-6.28%
|
$2,872,350
$39.18 P/Share
|
|
Aug 01
2024
|
Michael E Tarvin EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
28,937
-5.47%
|
$1,128,543
$39.18 P/Share
|
|
Aug 01
2024
|
Martin F Jackson EXECUTIVE VICE PRESIDENT |
SELL
Payment of exercise price or tax liability
|
Direct |
18,648
-1.35%
|
$727,272
$39.18 P/Share
|
|
Jul 30
2024
|
Parvinderjit S. Khanuja |
BUY
Grant, award, or other acquisition
|
Direct |
453
+1.03%
|
$17,667
$39.76 P/Share
|
|
Jul 30
2024
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
453
+0.16%
|
$17,667
$39.76 P/Share
|
|
May 09
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
BUY
Bona fide gift
|
Indirect |
200,000
+5.32%
|
-
|
|
May 09
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
SELL
Bona fide gift
|
Direct |
200,000
-29.85%
|
-
|
|
Apr 30
2024
|
Christopher Weigl CHIEF ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+27.27%
|
-
|
|
Apr 30
2024
|
Brian R. Rusignuolo Chief Information Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+17.29%
|
-
|
|
Apr 30
2024
|
Thomas P Mullin CO-PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+20.23%
|
-
|
|
Apr 30
2024
|
Martin F Jackson EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
138,000
+9.11%
|
-
|
|
Apr 30
2024
|
Michael F Malatesta CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+27.14%
|
-
|
|
Apr 30
2024
|
Michael E Tarvin EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
92,000
+14.81%
|
-
|
|
Apr 30
2024
|
John A. Saich EXECUTIVE VICE PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+12.19%
|
-
|
|
Apr 30
2024
|
Parvinderjit S. Khanuja |
BUY
Grant, award, or other acquisition
|
Direct |
10,634
+10.36%
|
$148,876
$14.19 P/Share
|
|
Apr 30
2024
|
Daniel Thomas |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+13.16%
|
-
|
|
Apr 30
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+3.22%
|
-
|
|
Apr 30
2024
|
David S Chernow PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
230,000
+16.4%
|
-
|
|
Apr 30
2024
|
Rocco A Ortenzio CHAIRMAN EMERITUS & CO-FOUNDER |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+12.99%
|
-
|
|
Apr 30
2024
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
10,634
+1.81%
|
$148,876
$14.19 P/Share
|
|
Apr 30
2024
|
James S. Ely Iii |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+6.34%
|
-
|
|
Apr 30
2024
|
Marilyn B Tavenner |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+15.63%
|
-
|
|
Apr 30
2024
|
Katherine R Davisson |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+17.86%
|
-
|
|
Apr 30
2024
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
BUY
Grant, award, or other acquisition
|
Direct |
7,000
+15.55%
|
-
|
|
Apr 30
2024
|
Thomas Scully Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+10.06%
|
-
|
|
Apr 30
2024
|
Russell L Carson Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+0.9%
|
-
|
|
Apr 28
2024
|
Robert G. Breighner Jr VICE PRESIDENT, COMPLIANCE |
SELL
Payment of exercise price or tax liability
|
Direct |
1,985
-6.02%
|
$53,595
$27.41 P/Share
|
|
Apr 08
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
50,000
-0.74%
|
$1,450,000
$29.9 P/Share
|
|
Mar 08
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
50,000
-0.74%
|
$1,400,000
$28.3 P/Share
|
|
Feb 12
2024
|
Parvinderjit S. Khanuja |
BUY
Grant, award, or other acquisition
|
Direct |
670
+2.02%
|
$17,420
$26.86 P/Share
|
|
Feb 12
2024
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
670
+0.24%
|
$17,420
$26.86 P/Share
|
|
Feb 08
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
50,000
-0.73%
|
$1,300,000
$26.0 P/Share
|
|
Jan 08
2024
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
100,000
-1.44%
|
$2,600,000
$26.63 P/Share
|
|
Dec 14
2023
|
Robert A Ortenzio EXECUTIVE CHAIRMAN |
SELL
Open market or private sale
|
Direct |
100,000
-1.42%
|
$2,500,000
$25.0 P/Share
|
|
Nov 01
2023
|
James S. Ely Iii |
BUY
Grant, award, or other acquisition
|
Direct |
798
+0.58%
|
$17,556
$22.56 P/Share
|
|
Nov 01
2023
|
William H. Frist |
BUY
Grant, award, or other acquisition
|
Direct |
798
+0.29%
|
$17,556
$22.56 P/Share
|